Takuya Suzuki

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma

Kenji Ikeda, Masatoshi Kudo, Seiji Kawazoe et al. · Journal of Gastroenterology · 2016 · 344 citations · Full text

Medicine, Oncology, Pharmacology +15

PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production

Takuya Suzuki, Yuta Suzuki, Taro Hihara et al. · International Journal of Pharmaceutics · 2020 · 208 citations

Pharmacy, Bioengineering, Pharmaceutics +13

Lenvatinib for Anaplastic Thyroid Cancer

Makoto Tahara, Naomi Kiyota, Tomoko Yamazaki et al. · Frontiers in Oncology · 2017 · 192 citations · Full text

Medicine, Oncology, Pharmacology +12

Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Masafumi Ikeda, Takuji Okusaka, Shuichi Mitsunaga et al. · Clinical Cancer Research · 2015 · 189 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16

A Phase II Study of the Safety and Efficacy of Lenvatinib in Patients with Advanced Thyroid Cancer

Shunji Takahashi, Naomi Kiyota, Tomoko Yamazaki et al. · Future Oncology · 2019 · 140 citations · Full text

Medicine, Oncology, Pharmacology +16